Results of intensive chemotherapy in chi
β
de Heredia, Cristina DΓaz; Ortega, Juan J.; Coll, MarΓa T.; Bastida, Pilar; Oliv
π
Article
π
1998
π
John Wiley and Sons
π
English
β 68 KB
π 2 views
Background. The use of chemotherapy in juvenile chronic myelomonocytic leukemia (J-CMML) has not generally been successful. Our previous experience in 11 patients demonstrated that chemotherapy with low doses of daunorubicin or cytarabine resulted in a 90% fatal outcome and a median survival rate of